This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Gaps in Vaccine Coverage Highlighted by New Report and Online Tool
    As the 69th World Health Assembly discusses progress on the Global Vaccine Action Plan, a new data visualization platform from the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health (JHSPH) provides stark numbers on where ...More
    1 week ago Posted in News
  • Putting the Brakes on Cell's 'Engine' Could Give Flu and Other Vaccines a Boost
    A relatively unknown molecule that regulates metabolism could be the key to boosting an individual's immunity to the flu -- and potentially other viruses -- according to research reported today in the journal Immunity. The study, led by University of Vermont (UVM) College ...More
    1 week ago Posted in News
  • New Strategy Could Yield More Precise Seasonal Flu Vaccine
    During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective. While this year’s vaccine is a much better match to the ...More
    2 weeks ago Posted in News
  • Zika Virus Protein Could Be Vaccine Target
    A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health (NIH) scientists and colleagues at Mount Sinai's Icahn School of Medicine. Their study, published online May 19, 2016 in Cell Host ...More
    2 weeks ago Posted in News
  • Large-Scale HIV Vaccine Trial to Launch in South Africa
    An early-stage HIV vaccine clinical trial in South Africa has determined that an investigational vaccine regimen is safe and generates comparable immune responses to those reported in a landmark 2009 study showing that a vaccine can protect people from HIV infection. ...More
    2 weeks ago Posted in News
  • Patients With Celiac Disease Should Receive Pneumococcal Vaccine
    Researchers have found that patients with celiac disease are at high risk of acquiring pneumonia if they haven't received the pneumococcal vaccine. When comparing 9,803 patients with celiac disease and 101,755 controls, the rate of pneumonia was similar; however, there was ...More
    3 weeks ago Posted in News
  • NIH-Led Team Discovers New HIV Vaccine Target
    A team led by scientists at the National Institutes of Health (NIH) has reported a research trifecta. They discovered a new vulnerable site on HIV for a vaccine to target, a broadly neutralizing antibody that binds to that target site, and how the antibody stops the virus ...More
    3 weeks ago Posted in News
  • HHS Pursues Development of Single-Dose Nasal Spray Anthrax Vaccine
    For the first time, one of the nation’s Centers for Innovation in Advanced Development and Manufacturing (CIADM) will support development of a second-generation anthrax vaccine under a task order issued by the U.S. Department of Health and Human Services’ Office ...More
    3 weeks ago Posted in News
  • Investigational Malaria Vaccine Protects Healthy U.S. Adults for More Than One Year
    An experimental malaria vaccine protected a small number of healthy, malaria-naïve adults in the United States from infection for more than one year after immunization, according to results from a Phase 1 trial described in the May 9 issue of Nature Medicine. The ...More
    4 weeks ago Posted in News
  • Danish Researchers Achieve Vaccine Breakthrough
    The next generation of vaccines may soon be on the horizon because Danish researchers have discovered a completely new and simple method which sets new standards for the development of vaccines. "The major research breakthrough is that we have created a general and ...More
    April 27, 2016 Posted in News
« Previous1234567891011114115Next »